Former president Joseph Biden has been diagnosed with advanced prostate cancer. We at the PCRI are saddened by this news, as this kind of a diagnosis is a radically life altering event that sends ripples through the lives of those diagnosed, and the community that surrounds them. Our thoughts and prayers are with the Biden family as they battle this harsh diagnosis.

Verne Varona has become an international renowned keynote speaker with a captivating style that uses humor, insight, and practical science to improve and enrich the lives of many. He studied traditional Chinese medicine and nutrition at the East West Foundation of Boston, Massachusetts.

On May 17, Howard Wolinski hosted an excellent interview with Dr. Jonathan Epstein for The Active Surveillor webinar series. Available now on The Surveillor’s YouTube channel, Dr. Epstein discusses key topics including which patients qualify for Active Surveillance, the significance of cribriform patterns, and the role of AI in prostate cancer management. A must-watch for anyone interested in the latest in prostate cancer care.

This event is a welcoming opportunity for patients to learn more about active surveillance, connect with others on a similar journey, and build a supportive community. Whether you're newly diagnosed or have been on surveillance for a while, you are warmly invited to be part of this conversation.

The US Food and Drug Administration (FDA) recently approved lutetium Lu 177 vipivotide tetraxetan (also known by the trade name PLUVICTO®) for the treatment of adult patients with prostate-specific membrane antigen (PSMA)-positive metastatic castration-resistant prostate cancer (mCRPC) who have been treated with androgen receptor pathway inhibitor (ARPI) therapy and who are considered appropriate to delay…